Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00685906 · ClinicalTrials.gov registry record · Phase 1
AZD6140 Oral Contraceptive Interaction Study
A Phase 1 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT00685906 is a Phase 1 study that has completed, run by AstraZeneca. The registered enrollment target is 24 participants.
The verdict
NCT00685906, a Phase 1 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effect of co-administration of AZD6140 and Nordette® on the blood levels of certain female hormones.
Interventions
- DRUG AZD6140
- DRUG Levonorgestrel and Ethinyl Estradiol (Nordette®)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-04 |
| Est. Completion | 2008-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00685906
The ClinicalTrials.gov registry entry for NCT00685906 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AZD6140 is the first listed.
NCT00685906 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00685906 about?
NCT00685906 is a clinical study titled "AZD6140 Oral Contraceptive Interaction Study". The purpose of this study is to examine the effect of co-administration of AZD6140 and Nordette® on the blood levels of certain female hormones.
What is the current status of trial NCT00685906?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2008-04. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00685906?
The interventions under investigation include: AZD6140 (DRUG), Levonorgestrel and Ethinyl Estradiol (Nordette®) (DRUG).
Who is sponsoring clinical trial NCT00685906?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.